# Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Study · id `cardio:ct-nct03666351` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03666351](<https://clinicaltrials.gov/study/NCT03666351>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03666351

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

## Technical summary

Registry record NCT03666351. Randomized; single masking; primary purpose treatment. Start 2018-10-18 (actual); primary completion 2022-07-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 128 participants (enrolled count; ClinicalTrials.gov record NCT03666351, source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)
- Started: 2018-10-18 (actual) (ClinicalTrials.gov record NCT03666351, source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)
- Primary completion: 2022-07-25 (actual) (ClinicalTrials.gov record NCT03666351, source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)
- Completion: 2022-07-25 (actual) (ClinicalTrials.gov record NCT03666351, source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03666351, source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03666351-2022-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
- Condition: Aortic Stenosis
- Condition: Aortic Regurgitation
- Condition: Hypertension
- Condition: LVM
- Condition: Left Ventricular Hypertrophy
- Intervention (Drug): Amlodipine 5mg
- Intervention (Drug): Losartan
- Intervention (Drug): Losartan and Amlodipine
- Intervention (Drug): Amlodipine/Losartan/Chlorthalidone
- Intervention (Drug): current treatment
- Lead sponsor: Hanmi Pharmaceutical Company Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Losartan (`cardio:losartan`)
- Registry lists this organization as the lead sponsor: Hanmi Pharmaceutical Company Limited (`cardio:org-hanmi-pharmaceutical-company-limited`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease (`cardio:pubmed-38006908`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fe3294a9e28f529d0762876c3b7314676e1c6896d6438236bc98aee7555e4d88
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
